Clementia Pharmaceuticals Inc. — key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2018)

-$58.1M

Total Assets (FY2018)

$176.8M

Total Equity (FY2018)

$164.4M

Cash Flows from Operating Activities (FY2018)

-$49.1M

Source: Clementia Pharmaceuticals Inc. 20-F filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.